What is Precision Diagnostics?
Precision Diagnostics operates at the intersection of clinical precision and high-volume laboratory services. By leveraging ultra-high sensitivity technology, the company provides essential diagnostic insights that support healthcare providers in making informed clinical decisions. Headquartered in San Diego, California, the organization has built a reputation for reliability and technical excellence in the toxicology and drug testing space.
The company's market position is defined by its ability to integrate advanced analytical methodologies with efficient, large-scale laboratory operations. As the demand for accurate, rapid diagnostic data continues to rise within the healthcare ecosystem, Precision Diagnostics remains a pivotal partner for institutions requiring rigorous testing standards and comprehensive analytical support.
How much funding has Precision Diagnostics raised?
Precision Diagnostics has raised a total of $16.5M across 2 funding rounds:
Debt
$14.5M
Debt
$2M
Debt (2015): $14.5M with participation from BelHealth Investment Partners
Debt (2020): $2M led by PPP
Key Investors in Precision Diagnostics
BelHealth Investment Partners
BelHealth Investment Partners is a premier growth partner focused on building healthcare businesses, managing significant assets to drive value across the medical industry.
PPP
Public-Private Partnership
What's next for Precision Diagnostics?
With the recent infusion of capital, Precision Diagnostics is well-positioned to accelerate its strategic initiatives, focusing on technological optimization and market expansion. The company is expected to leverage this financial backing to refine its diagnostic platforms, potentially increasing throughput and reducing turnaround times for its clinical partners.
Looking ahead, the firm will likely prioritize the integration of next-generation testing protocols to address the growing complexities of clinical diagnostics. By maintaining a focus on operational efficiency and high-sensitivity standards, Precision Diagnostics is poised to strengthen its footprint in the healthcare sector, ensuring that its diagnostic services remain at the forefront of industry requirements and patient care standards.
